Prevention of bone loss following spinal cord injury

ISRCTN ISRCTN46977778
DOI https://doi.org/10.1186/ISRCTN46977778
Secondary identifying numbers N0209132504
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
10/11/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Richard Keen
Scientific

RNOHT
Royal National Orthopaedic Hospital
Brockley Hill
Stanmore
HA7 4LP
United Kingdom

Phone +44 (0)20 8909 5314
Email richard.keen@ucl.ac.uk

Study information

Study designOpen label randomised controlled parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Scientific title
Study objectivesDo early interventions (drug or mechanical stimulation) reduce the risk of osteoporosis following spinal cord injury?

Please note that as of 16/04/10 this record has been updated and the information obtained from a recent publication of the results (details below). All updates can be found in the relevant field with the above update date.
Ethics approval(s)Added 16/04/10: Ethical approval was obtained from the Royal National Orthopaedic Hospital NHS Trust ethics committee
Health condition(s) or problem(s) studiedMusculoskeletal Diseases: Osteoporosis
InterventionPatients will be randomly assigned to either
1. Control group,
2. Group receiving zoledronate
3. Group receiving mechanical stimulation (vibration)
and receive the treatment over a 6 month period.
Bone Mineral Density and biochemical markers of bone metabolism will be assessed at the start of the study and at 3 and 6 months after intervention.
Intervention typeOther
Primary outcome measure1. Changes in Bone Mineral Density and biochemical markers of bone metabolism over time.
2. Difference between groups
Secondary outcome measuresNot provided at time of registration
Overall study start date01/08/2003
Completion date01/08/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants14 (added 16/04/10)
Key inclusion criteria1. Patients admitted to Royal National Orthopaedic Hospital (RNOH) with a spinal cord injury

Added 16/04/10:
2. Female patients had to be postmenopausal, surgically sterile or willing to practice a medically acceptable form of birth control during the study period and for at least 12 months after study completion
3. All subjects gave written consent to take part in the study
Key exclusion criteriaAdded 16/04/10:
1. Pregnant or breastfeeding
2. Previous history of allergic reaction to bisphosphonates
3. Previous history of iritis or uveitis
4. Significant renal impairment or evidence of vitamin D deficiency (serum 25-hydroxyvitamin D <25 nmol/L)
Date of first enrolment01/08/2003
Date of final enrolment01/08/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

RNOHT
Stanmore
HA7 4LP
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Royal National Orthopaedic Hospital NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2011 Yes No